| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.03 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |